The soluble ST2 level predicts risk of atrial fibrillation recurrences in long-term period after radiofrequency ablation-Reference-Cited by-同舟云学术

The soluble ST2 level predicts risk of atrial fibrillation recurrences in long-term period after radiofrequency ablation

Published:2024-08-28 Issue:1 Volume:24 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Gizatulina Tatiana P.,Mamarina Aleksandra V.,Martyanova Leysan U.,Belonogov Denis V.,Kolunin Grigoriy V.,Petelina Tatiana I.,Shirokov Nikita E.,Gorbatenko Elena A.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12872-024-04119-z.pdf

Reference27 articles.

1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;00:1–126. https://doi.org/10.1093/eurheartj/ehaa612.

2. Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical ablation of Atrial Fibrillation. Heart Rhythm. 2017. https://doi.org/10.1016/j.hrthm.2017.05.012.

3. Liu H, Wang K, Lin Y, et al. Role of sST2 in predicting recurrence of atrial fibrillation after radiofrequency catheter ablation. Pacing Clin Electrophysiol. 2020;43:1235–41.

4. Ma X, Yuan H, Luan HX, et al. Elevated soluble ST2 concentration may involve in the progression of atrial fibrillation. Clin Chim Acta. 2018;480:138–42.

5. Bayes-Genis A, de Antonio M, Vila J, Peñafiel J, Galán A, Barallat J, et al. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. J Am Coll Cardiol. 2014;63(2):158–66. https://doi.org/10.1016/j.jacc.2013.07.087.